Innovative Product Launches Troikaa Pharmaceuticals actively introduces new formulations such as Zolpidem Sublingual Spray and generation diclofenac spray, demonstrating their commitment to developing advanced treatments and expanding their product portfolio.

Growing Market Presence With a revenue range of 250 to 500 million USD and recent product launches, Troikaa presents ample opportunities to collaborate in emerging therapeutic segments like insomnia and NSAID alternatives.

Expanding Manufacturing Capabilities Operating three state-of-the-art manufacturing facilities across Ahmedabad and Dehradun positions Troikaa for increased production capacity, enabling potential partnerships in supply chain optimization and contract manufacturing.

Strong R&D Focus Troikaa’s consistent development of innovative drug delivery systems indicates a focus on research and development, open to opportunities in technological collaboration, formulation development, and quality enhancement.

Strategic Market Growth Recent hiring of key personnel like the head of corporate communications signals a strategic effort to boost brand visibility and market outreach, creating avenues for marketing and distribution partnerships.